A comparative analysis of males and females with breast cancer undergoing mastectomy using the American College of Surgeon’s National Surgical Quality Improvement Project (NSQIP) Parhom TowfighiRomina DeldarKenneth L. Fan Review 27 May 2022 Pages: 201 - 206
Identification of tumor biomarkers for pathological complete response to neoadjuvant treatment in locally advanced breast cancer Prarthana GopinathSridevi VeluswamiRajkumar Thangarajan Preclinical study 21 May 2022 Pages: 207 - 220
Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer Jie JuFeng DuPeng Yuan Preclinical study 14 June 2022 Pages: 221 - 230
Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer Masanori OshiShipra GandhiKazuaki Takabe Preclinical study 31 May 2022 Pages: 231 - 241
COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation Fumiaki SatoAtsunobu SagaraTetsuro Yumoto Preclinical study 28 May 2022 Pages: 243 - 256
Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS Idil ErogluVaradan SevilimeduMelissa L. Pilewskie Clinical trial 20 May 2022 Pages: 257 - 264
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature M. OpdamV. van der NoortS. C. Linn Clinical trial Open access 19 May 2022 Pages: 265 - 278
Biomarker profile of invasive lobular carcinoma: pleomorphic versus classic subtypes, clinicopathological characteristics and prognosis analyses Yu ZhangXiulan LuoZhang Zhang Clinical trial 06 June 2022 Pages: 279 - 295
The risk of PD-L1 expression misclassification in triple-negative breast cancer Shani Ben DoriAsaf AizicDov Hershkovitz Clinical trial Open access 27 May 2022 Pages: 297 - 305
Excision of breast fibroepithelial lesions: when is it still necessary?—A 10-year review of a regional centre Dorsa Mousa-DoustCarol K. DingeeElaine C. McKevitt Clinical trial 31 May 2022 Pages: 307 - 314
Association between body mass index and incidence of breast cancer in premenopausal women: a Japanese nationwide database study Takaaki KonishiMichimasa FujiogiHideo Yasunaga Clinical trial 04 June 2022 Pages: 315 - 325
Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction Orli Friedman-EldarJonathan BurkeMecker G. Möller Clinical trial 14 June 2022 Pages: 327 - 335
Racial disparities in neutrophil counts among patients with metastatic breast cancer during treatment with CDK4/6 inhibitors Ashley SchreierLaura Munoz-ArcosJesus D. Anampa Epidemiology 28 May 2022 Pages: 337 - 351
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark Cathrine F. HjorthPer DamkierDeirdre Cronin-Fenton Epidemiology Open access 30 April 2022 Pages: 353 - 363
Local and systemic therapy in breast cancer patients with central nervous system metastases Ninke E. A. WellerdieckPeter WesselsDieta Brandsma Epidemiology 09 June 2022 Pages: 365 - 384
The association between breast density and breast cancer pathological response to neoadjuvant chemotherapy C. CullinaneA. O. BrienR. Prichard Epidemiology Open access 23 May 2022 Pages: 385 - 392
Timely cancer genetic counseling and testing for young women with breast cancer: impact on surgical decision-making for contralateral risk-reducing mastectomy Shenin A. DettwylerDarcy L. ThullPhuong L. Mai Epidemiology 21 May 2022 Pages: 393 - 401
PALB2 germline mutations in a multi-gene panel testing cohort of 1905 breast-ovarian cancer patients in Argentina Ariana GonzalezFranco Del GrecoLina M. Nuñez Epidemiology 24 May 2022 Pages: 403 - 412
Association of markers of tumor aggressivity and cognition in women with breast cancer before adjuvant treatment: The Thinking and Living with Cancer Study James C. RootXingtao ZhouTim A. Ahles Epidemiology 19 May 2022 Pages: 413 - 422
Insulin resistance and weight gain in women treated for early stage breast cancer Grace Makari-JudsonRichard ViskochilWilson C. Mertens Epidemiology 21 May 2022 Pages: 423 - 431
Impact of genomic assays on treatment and outcomes in locally advanced breast cancer Omar PicadoDeukwoo KwonSusan B. Kesmodel Epidemiology 30 May 2022 Pages: 433 - 447
Breast reconstruction and quality of life five years after cancer diagnosis: VICAN French National cohort Memoli VictoriaBannier MarieBouhnik Anne-Déborah Epidemiology 24 May 2022 Pages: 449 - 461
Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype Ines Mesa-EguiagaraySarah H. WildJonine D. Figueroa Epidemiology Open access 01 June 2022 Pages: 463 - 473
Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population Jennifer L. Caswell-JinMaryam N. ShafaeeAllison W. Kurian Epidemiology 27 May 2022 Pages: 475 - 482
